Kyri K. Van Hoose

CIK: 0001860885

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (83.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

DRMA

Dermata Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

DRMA
Dermata Therapeutics, Inc.
Aug 16, 2026
Award(A)
Direct
102K shares-
DRMA
Dermata Therapeutics, Inc.
Jan 2, 2026
Award(A)
Stock Option (right to buy)
Direct
18K shares-
DRMA
Dermata Therapeutics, Inc.
Dec 23, 2025
Award(A)
Direct
122.5K shares-
DRMA
Dermata Therapeutics, Inc.
Dec 23, 2025
Disposition(D)
Warrant (Right to Buy)
Direct
7.9K shares-
DRMA
Dermata Therapeutics, Inc.
Jan 21, 2025
Award(A)
Direct
78.7K shares-
DRMA
Dermata Therapeutics, Inc.
Jan 13, 2025
Award(A)
Stock Option (right to buy)
Direct
20K shares-

		Type	Shares	Price		Ownership
Aug 16, 2026	DRMA Dermata Therapeutics, Inc.	Award(A)	102,040	-	$0	Direct
Jan 2, 2026	DRMA Dermata Therapeutics, Inc.	Award(A) Stock Option (right to buy)	18,000	-	-	Direct
Dec 23, 2025	DRMA Dermata Therapeutics, Inc.	Award(A)	122,549	-	-	Direct
Dec 23, 2025	DRMA Dermata Therapeutics, Inc.	Disposition(D) Warrant (Right to Buy)	7,874	-	-	Direct
Jan 21, 2025	DRMA Dermata Therapeutics, Inc.	Award(A)	78,741	-	$0	Direct
Jan 13, 2025	DRMA Dermata Therapeutics, Inc.	Award(A) Stock Option (right to buy)	20,000	-	-	Direct

1-6 of 6 transactions

About Van Hoose Kyri K.

Van Hoose Kyri K. (SEC CIK 0001860885) files insider reports with the SEC as SVP, CFO of Dermata Therapeutics, Inc. (DRMA).

Signal8 holds 5 ownership filings by Van Hoose Kyri K., all Form 4s, filed between Jan 14, 2025 and Aug 18, 2026. Those filings report 6 transactions, from Jan 13, 2025 to Aug 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Van Hoose Kyri K.'s filings is in SAN DIEGO, CA.

Recent filings by Van Hoose Kyri K.

Aug 16, 2026: Grant or award of DRMA shares (Form 4, code A).
Jan 2, 2026: Grant or award of DRMA derivative securities (Form 4, code A).
Dec 23, 2025: Grant or award of DRMA shares (Form 4, code A).
Dec 23, 2025: Disposition to issuer transaction of DRMA derivative securities (Form 4, code D).
Jan 21, 2025: Grant or award of DRMA shares (Form 4, code A).

Other insiders filing for Dermata Therapeutics, Inc. (DRMA)

PROEHL GERALD T, PRESIDENT, CHAIRMAN, CEO
Scott Kathleen D., Director
Bedoya-Toro Munera Maria E, SVP, Regulatory Affairs
WIERENGA WENDELL, Director
HALE DAVID F, Director
Nardo Christopher J., Senior VP, CDO

How to read Form 4 transaction codes